- $101.17m
- $109.14m
- $42.89m
- 70
- 91
- 40
- 74
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Interest Income | |||||
Interest Expense | |||||
Net Interest Income | 28.4 | 28.2 | 27.5 | 32.3 | 36.1 |
Loan Loss Provision | |||||
Net Interest Income After Loan Loss Provision | 27.3 | 26.5 | 28.2 | 33.2 | 35.7 |
Non Interest Income | |||||
Non Interest Expense | |||||
Net Income Before Taxes | 12.9 | 13.1 | 13.4 | 16.5 | 18.4 |
Provision for Income Taxes | |||||
Net Income After Taxes | 10.4 | 10.6 | 10.8 | 13.3 | 14.8 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 10.4 | 10.6 | 10.8 | 13.3 | 14.8 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 10.4 | 10.6 | 10.8 | 13.3 | 14.8 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 3.8 | 3.85 | 3.97 | 4.91 | 5.51 |
Dividends per Share |